Pharmacovigilance: empowering healthcare professionals and patients

被引：13
|
作者：
Steurbaut, Stephane [1 ,2 ]
Hanssens, Yolande [3 ]
机构：
[1] UZ Brussel, Dept Clin Pharmacol & Pharmacotherapy, B-1090 Brussels, Belgium
[2] Vrije Univ Brussel, Fac Med & Pharm, B-1090 Brussels, Belgium
[3] Hamad Gen Hosp, Dept Pharm, Doha, Qatar
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2014年 / 36卷 / 05期
关键词：
Adverse drug reaction; Drug safety; Health care professional; Patient; Pharmacovigilance; Spontaneous reporting; ADVERSE DRUG-REACTIONS; PHARMACISTS; ATTITUDES; PORTUGAL; REGION;
D O I：
10.1007/s11096-014-0004-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The European Union has thoroughly reformed its pharmacovigilance legislation in July 2012. Despite the changes, underreporting of adverse drug reactions remains a concern. This underreporting seems to be partially associated with incorrect customs and beliefs by healthcare professionals. Therefore, strengthening teaching and training in drug safety monitoring and reporting are essential. Sustained campaigns and education on pharmacovigilance are key elements to enhance its performance and effectiveness. In general, all healthcare professionals as well as patients should be more sensitized and empowered to contribute to pharmacovigilance programmes in order to improve drug safety.
引用
收藏
页码：859 / 862
页数：4
相关论文
共 50 条
12345